A detailed history of Saranac Partners LTD transactions in Boston Scientific Corp stock. As of the latest transaction made, Saranac Partners LTD holds 61,017 shares of BSX stock, worth $6.27 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares
61,017
Holding current value
$6.27 Million
% of portfolio
1.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Dec 05, 2025

BUY
$97.03 - $108.14 $5.92 Million - $6.6 Million
61,017 New
61,017 $5.95 Billion
Q2 2025

Dec 15, 2025

SELL
$89.7 - $107.41 $451,460 - $540,594
-5,033 Reduced 8.25%
55,984 $6.01 Billion
Q1 2025

Dec 15, 2025

SELL
$89.38 - $106.18 $322,483 - $383,097
-3,608 Reduced 5.91%
57,409 $5.79 Billion

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Saranac Partners LTD Portfolio

Follow Saranac Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saranac Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Saranac Partners LTD with notifications on news.